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ABSTRACT
Acute kidney injury (AKI) often associated with a high hospital morbi-mortality rate in the intensive care unit pa -
tients. Kidney injury molecule-1 (KIM-1), has many characteristics of ideal biomarker for kidney injury. The aim
of this study was to compared the temporal pattern of elevation urinary KIM-1 level following critically ill children
with SCr as standart biomarker of AKI. Prospective analytic observational study was conducted during October to
March 2014 in the Saiful Anwar General Hospital and Physiology Laboratory Brawijaya University. There were 13
critically ill as subjects. SCr and KIM-1 levels from all subjects were measured three times (at admission, after 1st
and 6th hour). Subjects were devided into AKI - non-AKI groups by SCr level and survivor – non survivor group
at the and of the observations. Results showed that there were significantly increased levels of KIM-1 in the AKI
and non-AKI and survivor-non survivor group at time point. However, we found that delta KIM-1 at time point
increased significant in non AKI group and survivor group. KIM-1 at admission can diagnosed AKI in critically ill
children. We conclude that urinary KIM-1 is a sensitive non-invasive biomarker to diagnosed acute kidney injury
in critically ill children. Increase level of KIM-1 by time shows protective and good outcome in critically ill chil -
dren.
Keyword: AKI, Critically ill, children, non-invasive biomarker urinary KIM-1 level
Acute  kidney  injury  (AKI)  is  characterized  by  a
sudden and generally reversible renal function impair-
ment, involving inability to maintain the homeostasis,
and may or not be accompanied by reduced diuresis.
During the childhood, the etiology of AKI are sepsis,
nephrotoxic drugs, and renal ischemia in criti¬cally ill
patients,  particularly  those  staying in  in¬tensive care
units (ICUs), are exposed to a number of conditions
which  may  result  in  renal  impairment,  thus  signifi-
cantly increasing 40-90% the morbi-mortality rate. Hy-
povolemia  leading  to  hypoperfusion  and  consequent
hypoxia;  inflammatory and thrombotic  events  caused
by sepsis; systemic inflammation from trauma, major
surgeries, drugs interfering with the renal hemodynam-
ics. Sepsis, and specially the septic shock, is one of the
main causes of AKI ntil now there were no data show
pediatric AKI incidence in Indonesia. In Sanglah Hos-
pital, Denpasar the incidence of pediatric AKI in pedi-
atric intensive care unit (PICU) is 16.77% [2], while in
PICU  Wahidin  Sudirohusodo  Hospital,  Makasar
80.05% critically ill patients had elevated of serum cre-
atinine (SCr) level [3]. In 2012, the incidence of AKI
in pediatric ward Saiful Anwar General Hospital is 4
cases per year and 1 cases per year in PICU [4]. At 3 to
5-year follow-up, 40% to 50% of pediatric patients who
had AKI show signs of chronic renal insufficiency, in-
dicating that sublethal injury permanently alters the re-
nal bed [5]. 
Serum creatinin (SCr) concentration is the surro-
gate  test  used  to  diagnose  AKI but  inadequate  gold
standard for several reasons. SCr has poor specificity in
the settings of prerenal azotemia, changes in dietary in-
take, and drug-induced changes in tubular secretion of
creatinine,  all  of  which  may  lead  to  change  in  SCr
without actual injury to the kidney, poor sensitivity in
the setting of adequate renal reserve,when SCr may not
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Figure 1. Flowchart of research subjects
change despite acute tubular injury because of compen-
satory increases in function by other nephrons.The use
of SCr may also lead to delays in diagnosis because of
the relatively slow kinetics of the rise in SCr after in-
jury [6].
KIM-1 (also known as TIM-1—T-cell immunoglob-
ulin and mucin-containing molecule)  is  a type I  cell
membrane glycoprotein containing in its extracellular
portion a 6-cysteine immunoglobulin-like domain and
a Thr/Ser-Pro rich domain characteristic of mucinlike
Oglycosylated proteins. The KIM-1 gene or protein ex-
pression is undetectable in normal kidney, present in
damaged tubular epithelial cells undergoing dedifferen-
tiation and replication, persist until the damaged cells
have completely recovered. 
KIM-1 was a phosphatidylserine receptor that con-
ferred  on  epithelial  cells  the  properties  of  highly
phagocytic  cells,  was  able  to  specifically  bind  phos-
phatidylserine on the apoptotic cell surface and trans-
form  tubular  epithelial  cells  into  semiprofessional
phagocytes, which enhanced the clearance of apoptotic
and  necrotic  cell  debris.  Functionally,  the  ability  of
KIM-1 to phagocytose apoptotic and necrotic cells in
the tubule of the kidney may be critical for remodeling
after injury to cleared of dead cell debris to relieve in-
tratubular obstruction. KIM-1 may play an important
role in limiting the autoimmune response to injury be-
cause phagocytosis of apoptotic cells mediated by KIM-
1 may result in the generation of antiinflammatory cy-
tokines and restrain the activation of proinflammatory
cytokines [7].
Research on urinary KIM-1 in animals and humans
has been done but has not been done before in criti-
cally  ill  children  in  Indonesia.  The  purpose  of  this
study is to compare the level of urinary KIM-1 with
SCr as conventional AKI biomarker at time point in
critically ill children.
Study design and subject
The  current  prospective  observational  analytic
study was used in critically ill children who was stay in
PICU/HCU/ER  Saiful  Anwar  General  Hospital,  be-
tween October 2013 and March 2014. A total of 15 out
of 28 critically ill children whose parents signed written
informed consent was selected as subjects. This study
protocol was approved by research ethical clearance, is-
sued by Health Research Ethics Commision, dr Saiful
Anwar General Hospital, Malang Indonesia. The out-
come was devided into 2 groups,  AKI and non-AKI
group on baseline examination then the changes of uri-
nary KIM-1 and serum creatinine level was measured
at the times point of admittions, 1 hour and 6 hour
hospitalization.
 
Inclusions criteria
Critically ill children, aged 1-18 years, treated in the
PICU/ ICU/ER, PaO2/FiO2 < 300 mmHg or use me-
chanical  ventilation,  hemodynamic  instability  or  re-
quiring  resuscitation  or  inotropic  drugs,  the  parents
willing to signed written informed consent  to follow
this research. Dropped out criteria are critically ill chil-
dren whose met  the inclusion criteria,  died  before  6
hour of admittions, or oligury during the time point of
observations, or catheterization contraindication.
Exclusions criteria
Children  with  renal  insufficiency  (nephrotic  syn-
drome,  nephritic  syndrome),  patients  who  received
hemodyalisis,  congenital  kidney  disease,  autoimmune
disease related to kidney, renal malignancy.
Operational definitions
Acute kidney injury (AKI) is sudden and generally
reversible renal function impairment, involving inabil-
ity to maintain the homeostasis, and may or not be ac-
companied by reduced diuresis.  AKI criteria in pedi-
atric standardized using pediatric risk injury failure loss
endstage (pRIFLE). Stage risk is  characterized by re-
duction  in  estimated  creatinine  clearance  (eCCl)  ≥
25% or a decrease in urine output 0.5 mL/kg/ h in 8
hours, stage injury is a reduction in estimated creati-
nine clearance (eCCl)  ≥ 50% or a decrease in urine
output 0.5 mL/kg/h in 16 hours, stage failure is a re-
duction  in  estimated  creatinine  clearance  (eCCl)  ≥
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75% or a decrease in urine output 0.3 mL/kg/ h in 24
hours  or anuria  within 12 hours.Children with high
risk AKI is critically ill children who are treated in an
intensive care unit (PICU/HCU) or ER who had expe-
rienced hypoxia, shock, sepsis, trauma, major surgery,
use  of  sedatives,  vasopressors,  radiological  contrast
nephrotoxic  drugs  that  interfere  with  renal  hemody-
namics. Critical illness was defined as a disturbance of
homeostasis  that  requires  treatment  in  an  intensive
care  unit  or  require  mechanical  ventilation  or
PaO2/FiO2  <  300  mmHg,  requiring  intravenous  in-
otropic  drugs  or  intravenous  vasoconstrictive  agents.
Disease severity defined by a score of pediatric logistic
organ dysfunction (PELOD score), patient stratification
scale  is  divided  into  3  scale,  low scale  (<10  points),
medium  scale  (10-19  points),  and  high  scale  (>20
points) with the highest point is 71.
Processing and storage of urinary samples
Urinary collections was taken with aseptic method
through  the  catheter  in  conjuction  with  serum
sampling  at  three  time  point  (on admittion,  1-hour,
and  6-hour  of  admittions).  Urinary  samples  then
centrifuged to seperate the particles of urine and stored
at  -20ºC.  Avoid  the  repeated  freezing  and  thawing
cycles.
Measurement of serum creatinine (SCr) level
Serum  creatinine  level  was  measured  at  the
Laboratory of Pathology Clinic, Saiful Anwar General
Hospital using enzymatic methode, Cobaz 6000.
Measurement of urinary KIM-1 level
Measurement  of  levels  of  urinary  KIM-1  was
conducted at the Laboratory of Physiology UB using
the Human TIM-1/KIM-1 / HAVCR immunoassay for
the  quantitative  determination  of  human  T-cell
immunoglobulin  mucin  (TIM-1)  concentrations  in
urine,  made by Quantikine ELISA (R & D system),
catalog  number  DKM-100.  This  assay  employs  the
quantitative sandwich enzymeimmunoassay technique.
A  monoclonal  antibody  specific  for  TM-1  has  been
precoated onto a microplate. Standarts and samples are
pipetted into the wells and any TIM-1 present is bound
by the immobilized antibody. After washing away any
unbound  substances,  an  enzyme-linked  polyclonal
antibody  specific  for  TIM-1  is  added  to  the  wells.
Following a wash to remove any unbound antibody-
enzyme reagent,  a substrate solution is added to the
wells  and  color  development  is  stopped  and  the
intensity of the color is measured.
Table 1. Characteristics of subjects based on AKI and non AKI
group in pediatric critically ill
Characteristic
n (%) Outcome
p
 AKI Non AKI
Total subject 13    
Sex    0.086c
Boys 6 (46) 4 2  
Girls 7 (54) 1 6  
Age (months)     
Average  58.40 62.62 0.085a
Standart  Deviations  ±45.64 ±52.66  
 1-5 years 8 (61.5)    
6-10 years 4 (30.8)    
 11-15 years 1 (7.7)    
BMI (kg/m2)     
Average  15.32 15.51 0.086a
Standart Deviations  ±2.10 ±2.51  
Nutritional status     
Malnourished 2 (15.4)    
Underweight 5 (38.5)    
Normal weight 4 (30.8)    
Overweight 2 (15.4)    
Lenght of stay     
Average  17.80 15.50 0.647a
Standart Deviations  ±10.96 ±6.82  
Admission in     
ER 1 (7.7)    
 HCU 8 (61.5)    
 PICU 4 (30.8)    
PELOD score    0.028a*
Average  4.34 2.08  
Standart Deviations  ±1.85 ±1.38  
Low risk 6 (46.2)    
Moderate risk 4 (30.8)    
High risk 3 (23.1)    
Predicted death rate (%)    0.031b*
Average  50.74 0.70  
Outcome    0.044c*
Survivor 5 (38) 0 5  
Non survivor 8 (62) 5 3  
Serum creatinine 
(mg/dL)     
Average 0 hour  0.49 0.45 0.794a
Average 1 hour  0.60 0.37 0.213b
Average 6 hour  0.72 0.32 0.020a*
Urinary KIM-1 (mg/dL)     
Average 0 hour  3.96 1.58 0.059a
Average 1 hour  4.61 2.07 0.141a
Average 6 hour  3.58 2.23 0.306b
a) Independent t-test; b) Mann-Whitney test; c) Chi-square; *) Significant
p<0.05
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Statistical analysis
The differences KIM-1 level and serum creatinine
at time point between AKI and non AKI group or sur-
vivor and non survivor were analyzed using indepen-
dent t-test, then analyzed receiver operating character-
istic (ROC) was performed to predict the presence of
early AKI in critically ill children. The statistic analysis
used a statistical package for the social sciences (SPSS
15.0) for Windows.
Table  1  shows  subjects’s  characteristics  based  on
gender, age, BMI, lenght of stay, the mean of serum
creatinine levels and urinary KIM-1 level between AKI
and  nonAKI  group.  Only  PELOD scores,  predicted
death rate, outcome show significant (p <0.05). Lenght
of stay of AKI group in pediatric critically ill is 17 days
while  nonAKI  is  15  days.  Score  PELOD  is  one  of
MODS score in pediatric critically child that associated
with increased mortality.8 Research conducted by Le-
teurtre et al. (2010) state that the first day of  PELOD
scores  associated  with  significant  prognostic  factor
(odds ratio 1.16 that increase in every point, 95% CI)
and the score 10-20 PELOD increase mortality of pedi-
atric critically ill patients in the PICU.9
Refer to Figure 2A. found no significant difference
in the urinary KIM – 1 level and between AKI and
non AKI groups at time point (independent t-test p>
0.05),  at  admission,  1  hour  and  6  hour  respectively
p=0.059, p=0.141, 0=0.306. Using pairwaise comparison
to measured delta urinary KIM-1 level between time
point  we  found  significan  between  0  to  1  hour
(p=0.011). 
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Figure 2. The level of urinary KIM-1 and serum creatinine at time point. (a) Urinary KIM-1 level between AKI and non AKI group
and (b) Serum creatinine between AKI and nonAKI group; (c) Urinary KIM-1 level between survivor and non survivor
and (d) Serum creatinine level between survivor and non survivor group
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Table 2. Area under curve ROC urinary KIM-1 and
serum creatinine
Variable Area Under Curve (95% CI) p
KIM-1 0 hour 0.850 (95% CI=0.630 to 1.070) 0.040*
KIM-1 1 hour 0.700 (95% CI=0.392 to 1.008) 0.242
KIM-1 6 hour 0.675 (95% CI=0.345 to 1.005) 0.306
Serum creatinine 0
hour
0.575 (95% CI=0.246 to 0.904) 0.661
Serum creatinine 1
hour 
0.712 (95% CI=0.426 to 0.999) 0.213
Serum creatinine 6
hour
0.900 (95% CI=0.727 to 1.073) 0.019*
*) p< 0.05 significant
Refer to Figure 2C at the 0 hour or the initial ob-
servation  there  were  no  difference  between  urinary
KIM-1 levels in survivor and non survivor as well as 1
and 6 hour admission (Mann-Whitney U test respec-
tively p=0.057, p=0.188, and p=0.242). Using Wilcoxon
test  (post  hoc Friedman)  we found  significantly  in-
creased  delta  urinary  KIM-1  level  between  0-1  hour
and 0-6 hour  in  survivor  group respectively  p=0.043
and p=0.043. 
Refer  to  Figure  2B  serum creatinine  levels  mea-
sured at the 0, 1, and 6 hour after admissions. There
were no significant different between 0 and 1 hour ad-
mission between AKI  and  non  AKI group but  at  6
hour it  show significant  different  (independent  t-test
p=0.020) while Figure 2D showed that there were no
significant different serum creatinin level between sur-
vivor and non survivor at time point (independent t-
test respectively p=0.347, p=0.608, and p=0.178). 
Kidney injury molecule- 1 (KIM-1) is a transmem-
brane protein in humans that are not detected in urine
of subject’s normal kidney tissue in normal conditions
but expressed in very high levels in proximal tubular
epithelial cells undergo dedifferentiation [10].  In this
study urinary KIM-1 level found no significant differ-
ence at time point between AKI and non AKI groups.
This study is similar to research conducted by Bogh-
dady et al. (2013) in adult critically ill patients that the
levels  of  urinary KIM-1 level  at  admissions the ICU
did not differ significantly in AKI and non AKI group
but that study found significant differences in the 6 –
12 hour of admissions [11]. Other research states that
the  expression  of  KIM-1  is  slower  than  the  urine
NGAL in patients after cardiac surgery. This can be ex-
plained by the presence of subclinical injury that oc-
curred outside of the renal proximal tubule or even se-
vere damage of proximal tubular epithelial cells becau-
 Figure 3. Urinary KIM-1 (a) and serum creatinine ROC (b)
se of KIM-1 is a transmembrane glycoprotein is con-
fined only to the surviving proximal tubular epithelial
cells after the injury [12].
In this study found no significant difference in the
levels of urinary KIM-1 between survivor and non sur-
vivor in time point but it was found a significant differ-
ence in the levels of urinary KIM-1 0-1 hours and 0-6
hours  admissions  in  survivor.  The  trends  tendency
found that the levels of urinary KIM-1 non survivor is
higher than survivor. Research conducted by Han et
al.. (2002) stated that urinary KIM-1 was significantly
increased in patients ischemic ATN 12 hours after is-
chemic injury [13]. High urinary KIM-1 expression is
associated with poor clinical outcome in AKI patients
[11, 14]. Research conducted by Van Timmeren et al.
(2007) stated that the levels of urinary KIM-1 related
to the degree of renal tubular damage histopathology
[15]. While the tendency found that the levels of sur-
vivor urinary KIM-1 continues to increase until hours
to 6 treatments. Research conducted by Ichimura et al..
(2008)  stated  that  the  KIM-1  mediates  clearance  of
apoptotic and necrotic debris in the tubular lumen and
triggers apoptosis mediated internalization when bind-
ing to the cell surface. Phagocytosis of apoptotic cells
led to an increase of anti-inflammatory cytokines that
resist  the activation of proinflammatory cytokines, as
well as hepatocyte growth factor (HGF), known as re-
nal repair factor, increased in epithelial cells phagocy-
tize  apoptotic  cells  [16].  Urinary  KIM-1  increased
along with the increase in bromodeoxyuridine (prolif-
eration marker) and elastin (dedifferentiation marker)
so that the KIM-1 plays a role in the regeneration of
tubular epithelial cells [7]. So that researchers can only
speculate that urinary KIM-1 has a detrimental effect
in a harmful and protective mechanism [15]. Increased
levels of urinary KIM-1 related to the degree of renal
tubular damage associated with death, but on the other
side of the KIM-1 urinalysis provide a protective effect
by  inducing  apoptosis  and  anti-inflammatory  cy-
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tokines.
In this  study there were significant differences  in
serum creatinine levels between patients between AKI
and non AKI group at 6 hour admissons.  However,
there no significant differences at time point between
survivor and non survivor. In other hand the tendency
of serum creatinine levels in non survivor increased at
time point while decreased in survivor. Research con-
ducted by Newsome et  al.  (2008)  suggest  that  small
changes in serum creatinine levels during treatment in-
creases the risk of terminal renal failure and death.17
Increased of serum creatinine 0.3 mg/dL or more asso-
ciated with poor clinical outcome.18 A similar study is
showed by Nin et al. (2009) who examined the serum
creatinine levels in patients undergo mechanical venti-
lation that small changes of serum creatinine in the ad-
missions  while  many  clinicians  do  not  react  with
changes of 0.3 mg/dL were associated with poor out-
come. From this study it was found that delta serum
creatinine of more than 0.31 mg/dL increase of 1.37
times  the  risk  of  death  in  patients  with  mechanical
ventilation (95 % CI) [19].
Table 2 shows that AUC of urinary KIM-1 at ad-
mission 0.850 (> 0.7) with a p value of 0.040, so it can
be used to predict  the AKI in pediatric  critically  ill.
Meanwhile, the levels of KIM-1 AUC at 1 hour and 6
hour is 0.700 (p = 0.242) and 0.675 (p = 0.306) so it
can not be used as a predictive AKI. The AUC of crea-
tinine levels at 6 hour is 0.900 (> 0.7) with p = 0.019,
which means creatinine levels to-6 hours can be used
as a predictor AKI.
Figure 3A shows the ROC curve levels of KIM-1
hour 0 is 0.850 (95% CI = 0.630 to 1.070), p = 0.040.
Based on the ROC curve  can be  determined cut-off
value for AKI classification. ROC curve analysis of the
urine levels of KIM-1 0 hour is 2.11 ng/dL (Table 3).
AUC of creatinine 6 hour (red line on Figure 3b) is
0.900 (95 % CI = 0.727 to 1.073) p = 0.019. From the
ROC curve analysis of 6 hour creatinine levels,  note
that  the  cut-off point  for  predicting creatinine  levels
AKI output is 0.465 mg/dL.
Table 3. Cut off of urinary KIM-1 at admission
Variable Outcome
AKI Non AKI
Urinary KIM-1 at 0 hour
 2.11 ng/dL≥ 4 (31%) 1 (8%)
 2.11 ng/dL˂ 1 (8%) 7 (54%)
This  is  in line  with research by Prozialeck et  al.
(2009) which states that the increased of urinary KIM-
1 earlier than the increase in serum creatinine [20]. Re-
search conducted by Han et al. (2002) in critically ill
adult patients showed that the ranges of urinary KIM-1
levels were 1.34 ng/dL to 2.99 ng/dL [13]. In a study
conducted by Han et al. (2008) in patients whose done
cardio pulmonary baypass found increased of urinary
KIM-1 level  at  6-12 hours  after  surgery and urinary
KIM-1 AUC at 2 hour admissions was 0.57, while 12
and 24 hour was respectively 0.83 and 0.78 [21]. Re-
search conducted by Liangos et  al.  (2009) states that
between  6  urinary  biomarkers  studied  in  cardiac
surgery  patients,  urinary  KIM-1  has  a  good  perfor-
mance to predict AKI 2 hours after surgery with AUC
0.78 [22].
There are several  limitation of the current result.
The subject follow the study is relative small so the fu-
ture study need a large number of pediatric critically ill
in multicenter research. The increased levels of urinary
KIM-1  significantly  at  6-12  hours  after  renal  injury
need  longer  examination  of  serial  urinary  levels  of
KIM-1. 
Figure 4. Urinary  KIM-1 and  serum creatinine  level  at  time
point
Our study state that urinary KIM-1 is a sensitive
non-invasive biomarker to diagnose AKI in critically ill
children. Increase level of KIM-1 by time shows AKI
protective and good outcome. Urinary KIM-1 has good
sensitivity  and  spesifisity  to  early  diagnose  AKI  in
critically ill children.
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